Skip to content
Review

Advances in cascaded CRISPR for preamplification-free nucleic acid assays.

Sep 2026 · Biosensors & bioelectronics · Vol 314, pp. 119197 · 0 citations · 64 references
Medicine

TL;DR

The design principles and working mechanisms of cascaded CRISPR strategies, encompassing Enzyme-Coupled cascades, Multi-effector class 2 CRISPR cascades, and Type III CRISPR-mediated cascades are introduced, including integration with digital detection platforms and AI-assistant algorithms are discussed.

Abstract

The development of rapid, sensitive, and specific nucleic acid assays is pivotal for advancing molecular detection in clinical diagnosis, food safety, and environmental monitoring. Clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) systems, renowned for their programmable and signal amplification capacity, have emerged as efficient tools for meeting these challenges. However, the intrinsic sensitivity of CRISPR/Cas assays relying on a single Cas effector is typically confined to the picomolar level, often necessitating complex nucleic acid preamplification. Cascaded CRISPR systems, which integrate sequential enzymatic reactions or multiple CRISPR effectors, can address this limitation by achieving nucleic acid preamplification-free signal enhancement. This review starts with the introduction of the design principles and working mechanisms of cascaded CRISPR strategies, encompassing Enzyme-Coupled cascades, Multi-effector class 2 CRISPR cascades, and Type III CRISPR-mediated cascades. Then, we highlight the deployment of these techniques across diverse bio-sensing scenarios, ranging from disease diagnosis to food and environmental surveillance. Finally, critical challenges and emerging frontiers are discussed, including integration with digital detection platforms and AI-assistant algorithms.

View source

Similar papers

Review Open access Aug 2026

Research Progress in Applications of the CRISPR-Cas12b System in Pathogen Nucleic Acid Detection

A comprehensive evaluation of current applications demonstrates the efficacy of CRISPR-Cas12b-based diagnostics across diverse pathogens, including viruses, bacteria, and parasites, with a specific focus on its integration with isothermal amplification techniques.

Jiang-Ying Li, Xue-Yong Zhang · 0 citations
Review Aug 2026

CRISPR RNA Engineering Enables Single Nucleotide Polymorphism Discrimination in Nucleic Acid Detection.

This review synthesizes current advances aimed at enhancing the specificity of CRISPR diagnostics with particular emphasis on the pivotal role of CRISPR RNA (crRNA) engineering, and details how structural determinants of crRNA govern CRISPR-mediated target recognition and define the energetic and kinetic thresholds for...

Tianrui Sun, Aijiao Yuan, Wenjing Xie et al. · 0 citations

One-Pot Isothermal Linear Amplification and Cas12a-Based Nucleic Acid Detection

CATNAP (Cas trans -nuclease detection of amplified products), a method that integrates isothermal linear DNA amplification with Cas12a detection in a single reaction, bridges the sensitivity gap in CRISPR diagnostics while maintaining simplicity, making accurate disease detection more accessible in resource-limited setti...

Selma Sinan, Remy M. Kooistra, Karunya Rajaraman et al. · 0 citations
Open access Sep 2026

Harmonizing amplification and cleavage kinetics through crRNA scaffold mutation enables robust one-pot CRISPR-Cas12 diagnostics.

CRISPR-based diagnostics (CRISPR-Dx) integrated with isothermal nucleic acid amplification have emerged as a promising strategy for point-of-care molecular testing. Their practical deployment, however, remains constrained by workflow-related limitations. Conventional two-step formats are laborious and highly susceptibl...

Qing-Yang Jiang, Rui-Quan Xu, Zhi-Xin Lin et al. · 0 citations
Sep 2026

Universal CRISPR/Cas12a-G4 DNAzyme biosensing platform for rapid detection of nucleic acid and non-nucleic acid targets.

The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) system enables sensitive and specific biomolecular detection due to its programmability, high fidelity, and signal amplification. Herein, a novel universal CRISPR/Cas12a-G4 DNAzyme-TMB (Cas-GT) enzymatic biosensi...

Huisi Qin, Jing-Xuan Liu, Yang Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.